Insufficient scRNA-seq data for expression of IRX6 at single-cell level.
Insufficient scRNA-seq data for expression of IRX6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 72% | 958.06 | 1305 / 1809 | 77% | 17.42 | 362 / 472 |
breast | 98% | 775.25 | 448 / 459 | 23% | 1.71 | 256 / 1118 |
adipose | 97% | 1131.23 | 1170 / 1204 | 0% | 0 | 0 / 0 |
lung | 51% | 260.22 | 292 / 578 | 46% | 6.41 | 534 / 1155 |
eye | 0% | 0 | 0 / 0 | 96% | 18.47 | 77 / 80 |
kidney | 33% | 124.72 | 29 / 89 | 47% | 8.32 | 423 / 901 |
tonsil | 0% | 0 | 0 / 0 | 73% | 14.80 | 33 / 45 |
muscle | 69% | 237.38 | 552 / 803 | 0% | 0 | 0 / 0 |
spleen | 57% | 136.24 | 138 / 241 | 0% | 0 | 0 / 0 |
thymus | 21% | 43.16 | 140 / 653 | 26% | 5.02 | 160 / 605 |
uterus | 9% | 24.78 | 15 / 170 | 39% | 4.64 | 177 / 459 |
heart | 45% | 480.43 | 387 / 861 | 0% | 0 | 0 / 0 |
esophagus | 14% | 28.69 | 203 / 1445 | 31% | 3.12 | 56 / 183 |
ovary | 4% | 5.98 | 8 / 180 | 20% | 1.69 | 87 / 430 |
adrenal gland | 1% | 0.82 | 2 / 258 | 13% | 1.27 | 29 / 230 |
brain | 11% | 23.44 | 286 / 2642 | 1% | 0.08 | 10 / 705 |
prostate | 10% | 19.36 | 24 / 245 | 1% | 0.03 | 5 / 502 |
blood vessel | 11% | 36.37 | 141 / 1335 | 0% | 0 | 0 / 0 |
intestine | 8% | 15.70 | 75 / 966 | 1% | 0.10 | 6 / 527 |
bladder | 0% | 0 | 0 / 21 | 8% | 1.47 | 38 / 504 |
stomach | 2% | 3.83 | 7 / 359 | 2% | 0.15 | 5 / 286 |
liver | 0% | 0 | 0 / 226 | 4% | 0.31 | 15 / 406 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.11 | 5 / 178 |
peripheral blood | 2% | 5.74 | 19 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030182 | Biological process | neuron differentiation |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0048468 | Biological process | cell development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | IRX6 |
Protein name | Iroquois-class homeodomain protein IRX-6 (Homeodomain protein IRXB3) (Iroquois homeobox protein 6) |
Synonyms | IRX7 IRXB3 |
Description | FUNCTION: Transcription factor. Binds to the iroquois binding site (IBS) motif of target genes to regulate gene expression; functions as a transcriptional activator or repressor. Modulates expression of RCVRN, VSX1, BHLHE22/BHLHB5 and TACR3/Nk3r. Required downstream of retinal bipolar cell specification for the terminal differentiation of type 2, type 3a and possibly type 6 bipolar cells. . |
Accessions | P78412 ENST00000290552.8 |